Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
Clinical trial NCT04824092 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04824092
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-11
- Primary completion
- 2026-09-01
- Enrollment
- 899
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.